logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Mania

    Medications for Mania

    FiltersReset Filters
    4 results

    • aripiprazole

      (ARIPIPRAZOLE)
      Accord Healthcare, Inc.
      Usage: Aripiprazole tablets are indicated for the treatment of schizophrenia, acute manic and mixed episodes in bipolar I disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder.

    • asenapine

      (asenapine maleate)
      Greenstone LLC
      Usage: Asenapine sublingual tablets are indicated for the treatment of schizophrenia in adults and bipolar I disorder, including acute manic or mixed episodes in patients aged 10 to 17. It is also used as adjunctive treatment with lithium or valproate and for maintenance monotherapy in adults.

    • asenapine

      (Asenapine)
      Alembic Pharmaceuticals Limited
      Usage: Asenapine is indicated for Bipolar I disorder, including acute monotherapy of manic or mixed episodes in pediatric patients aged 10 to 17 years, and as adjunctive treatment with lithium or valproate in adults.

    • lithium carbonate

      (Lithium Carbonate)
      Rising Pharma Holdings, Inc.
      Usage: Lithium Carbonate Extended-Release Tablets are indicated for treating manic episodes of manic-depressive illness and for maintenance therapy to prevent or reduce the intensity of future episodes in patients with a history of mania. Symptomatic improvement typically occurs within 1 to 3 weeks.